Related Experiment Video
Updated: Jan 6, 2026

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury
Published on: December 17, 2014
Cationic Liposome-Mediated Bcl-2 Gene Transfection in Bone Marrow Mesenchymal Stem Cells: A Novel Regenerative
Haitao Yuan1, Xiaojun Feng1, Kamran Hidayat Ullah2
1Department of Orthopedics, Xishan People's Hospital Of Wuxi City, Wuxi, Jiangsu, 204105, People's Republic of China.
Objective:
This study explored a novel therapy for spinal cord injury (SCI) using cationic liposomes to deliver the anti-apoptotic Bcl-2 gene into rat bone marrow mesenchymal stem cells (BMSCs), followed by transplantation into a rat SCI model to evaluate its potential in promoting neural regeneration and enhancing SCI therapy.
Methods:
BMSCs were isolated and characterized for surface markers and differentiation potential, and transfected with Bcl-2 via cationic liposomes. A rat SCI model was established to assess the therapeutic effects of BMSCs and Bcl-2-BMSCs. Functional recovery was evaluated using the Basso, Beattie, and Bresnahan (BBB) scale and inclined plate test, while histopathology, Western blot, and real-time polymerase chain reaction (RT-PCR) analyses were performed to assess neural recovery. Nissl and myelin staining were used to evaluate neuronal and myelin recovery.
Results:
Following successful characterization of BMSCs and the spherical cationic liposomes (105 ± 1.3 nm, 18.65 ± 1.37 mV zeta potential), optimal transfection conditions were identified. Bcl-2-transfected BMSCs expressed high levels of Bcl-2 with low toxicity. In addition, the SCI results showed significant improvements in the BBB and inclined plate scores of rats in the BMSCs and Bcl-2-BMSCs groups compared to the model group (p< 0.01). HE-stained samples demonstrated that the secretion of Bcl-2 and BMSCs plays a crucial role in SC repair. Western blot results revealed an upregulation of proteins associated with neural recovery (Bcl-2, β-tubulin3, MAP2, NF-200, MBP) and a downregulation of the glial scar-associated protein GFAP in both the BMSCs and Bcl-2-BMSCs groups. Furthermore, Nissl staining and myelin staining showed that both the BMSCs and Bcl-2-BMSCs groups exhibited enhanced neuronal survival, inhibition of demyelination, and significant myelin regeneration.
Conclusion:
Transplantation of Bcl-2-transfected BMSCs represents a highly promising strategy that effectively promotes neural regeneration, inhibits scar formation, reduces demyelination, and enhances functional recovery, highlighting its potential for clinical translation.
More Related Videos
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
11:37Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...